Reset filter
Keywords
Off-Treatment ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

95 Search results.

Relevance Rating New first Old first

Brain and Central Nervous System Tumors NCT00053963 Off Treatment - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] - 2077867v3.0 - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212]

- 1/9/15 - 1 form, 4 itemgroups, 28 items, 1 language
Itemgroups: Header,Patient Status Information,Events of Interest,CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B24316ED-D5DA-16A3-E034-0003BA12F5E7

Breast Cancer NCT00090974 Off Treatment - OFF TREATMENT FORM (OPT) - 2058934v3.0 - OFF TREATMENT FORM (OPT)

- 1/9/15 - 1 form, 7 itemgroups, 22 items, 1 language
Itemgroups: PATIENT INFORMATION,OFF PROTOCOL THERAPY,UNBLINDING,Header,COMMENTS,INVESTIGATOR SIGNATURE,CCRR MODULE
OFF TREATMENT FORM (OPT) Quality Of Life Companion Study For JMA27 (NCIC-MA.27): A Randomized Phase III Trial Of Exemestane Versus Anastrozole With Or Without Celecoxib In Postmenopausal Women With Receptor Positive Primary Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ABE19FE8-ADA4-53BD-E034-0003BA12F5E7

Neuroblastoma NCT00053326 Off Treatment - ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master) - 2089607v3.0 - ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master)

- 1/9/15 - 1 form, 4 itemgroups, 26 items, 1 language
Itemgroups: Header,Patient Status Information,Events of Interest,CCRR MODULE
ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master) Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9B484F8-51DB-1EF7-E034-0003BA12F5E7

Lung Cancer NCT00049543 Off Treatment - Off Treatment Form - 2034390v3.0 - Off Treatment Form

- 1/9/15 - 1 form, 9 itemgroups, 36 items, 1 language
Itemgroups: 1. PATIENT INFORMATION,2. OFF PROTOCOL THERAPY,NCIC CTG use only2,NCIC CTG use only,Header,3. UNBLINDING,4. COMMENTS,5. INVESTIGATOR SIGNATURE,CCRR MODULE
Off Treatment Form Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A069F1F1-C7BA-50DA-E034-080020C9C0E0

Breast Cancer NCT01272037 Off Treatment - S1007 Notice of Death Form - 3140582v1.0 - S1007 Notice of Death Form

- 1/9/15 - 1 form, 4 itemgroups, 22 items, 1 language
Itemgroups: Header Module,Date of Death,CAUSES OF DEATH,Comments
S1007 Notice of Death Form (49467) Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=90D9C2DE-6ACF-8071-E040-BB89AD430CF6

Lung Cancer NCT00049543 Off Treatment - Emergency Unblinding Form - 2279706v3.0 - Emergency Unblinding Form

- 1/9/15 - 1 form, 3 itemgroups, 14 items, 1 language
Itemgroups: 1. Patient Information,2. Unblinding Information,3. Signature
Emergency Unblinding Form Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D98AA788-C380-49AB-E034-0003BA12F5E7

Ovarian Cancer NCT00993655 Off Treatment - NCIC OV 21 Death Report Form - 2874203v1.0 - NCIC OV 21 Death Report Form

- 1/9/15 - 1 form, 4 itemgroups, 15 items, 1 language
Itemgroups: Patient Information,DATE/CAUSE OF DEATH/AUTOPSY,Comments,Contact Information
NCIC OV 21 Death Report Form Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=69B794A7-2EA4-1666-E040-BB89AD432FB9

Breast Cancer NCT01101438 Off Treatment - NCIC MA.32 End of Treatment Form - 3018635v1.0 - NCIC MA.32 End of Treatment Form

- 1/9/15 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: END OF TREATMENT,END OF TREATMENT GLUCOSE
NCIC MA.32 End of Treatment Form A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=80D68B0D-F9C5-D6E6-E040-BB89AD43104A

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Off Treatment Notice Revised - 2169415v3.0 - CALGB: 90104 Off Treatment Notice Revised

- 1/9/15 - 1 form, 1 itemgroup, 20 items, 1 language
Itemgroup: CCRR MODULE
CALGB: 90104 Off Treatment Notice Revised Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B4CED-A464-70DB-E034-0003BA12F5E7

Breast Cancer NCT01101438 Off Treatment - NCIC MA.32 Death Report Form - 3017307v1.0 - NCIC MA.32 Death Report Form

- 1/9/15 - 1 form, 4 itemgroups, 16 items, 1 language
Itemgroups: DATE/CAUSE OF DEATH,AUTOPSY,ADVERSE EVENTS - DEATH REPORT,CARDIOVASCULAR MOBIDITY
NCIC MA.32 Death Report Form A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=805B03D5-89D0-F93C-E040-BB89AD433826

Lung Cancer NCT01336894 Off Treatment - ACOSOG-Z4099 End of Intervention Form - 3178441v1.0 - ACOSOG-Z4099 End of Intervention Form

- 1/9/15 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Header Module,Off-Treatment Reason
ACOSOG-Z4099 End of Intervention Form Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9869A599-BCAB-139E-E040-BB89AD432862

Breast Cancer NCT01242800 Off Treatment - E2108 End-of-Study Form - 3128917v1.0 - E2108 End-of-Study Form

- 1/9/15 - 1 form, 6 itemgroups, 21 items, 1 language
Itemgroups: Header Module,Header,Amended Data,Vital Status,Section I,Comments
E2108 End-of-Study Form Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8DF34112-9349-8BCA-E040-BB89AD4347FD

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial